In addition, transcriptome sequencing and IF staining further revealed decreased expression of NQO1, but not of VKORC1, in a dose-dependent manner with DCM treatment (Fig. 5d–g). This evidence concerns the gene NQO1 and familial dilated cardiomyopathy.